Atle Fund Management AB as of March 31, 2025
Portfolio Holdings for Atle Fund Management AB
Atle Fund Management AB holds 37 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 12.6 | $29M | 35k | 825.91 | |
| Abbvie (ABBV) | 8.3 | $19M | 89k | 209.52 | |
| UnitedHealth (UNH) | 6.0 | $14M | 26k | 523.75 | |
| Boston Scientific Corporation (BSX) | 5.9 | $13M | 132k | 100.88 | |
| Merck & Co (MRK) | 5.1 | $12M | 128k | 89.76 | |
| Thermo Fisher Scientific (TMO) | 5.0 | $11M | 23k | 497.60 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.9 | $11M | 23k | 484.82 | |
| AmerisourceBergen (COR) | 3.9 | $8.8M | 32k | 278.09 | |
| Gilead Sciences (GILD) | 3.8 | $8.6M | 77k | 112.05 | |
| Stryker Corporation (SYK) | 3.8 | $8.6M | 23k | 372.25 | |
| Neurocrine Biosciences (NBIX) | 3.7 | $8.4M | 76k | 110.60 | |
| Amgen (AMGN) | 3.7 | $8.3M | 27k | 311.55 | |
| Isrg Us Equity Com New (ISRG) | 3.4 | $7.6M | 15k | 495.27 | |
| Alks Us Equity SHS (ALKS) | 3.1 | $7.1M | 215k | 33.02 | |
| Onc Us Sponsored Ads (ONC) | 3.0 | $6.8M | 25k | 272.17 | |
| Bridgebio Pharma (BBIO) | 2.3 | $5.2M | 151k | 34.57 | |
| Edwards Lifesciences (EW) | 1.9 | $4.3M | 60k | 72.48 | |
| UFP Technologies (UFPT) | 1.9 | $4.3M | 21k | 201.71 | |
| Krystal Biotech (KRYS) | 1.9 | $4.2M | 24k | 180.30 | |
| Cardinal Health (CAH) | 1.7 | $3.8M | 28k | 137.77 | |
| Mirum Pharmaceuticals (MIRM) | 1.5 | $3.5M | 77k | 45.05 | |
| Dex (DXCM) | 1.4 | $3.1M | 46k | 68.29 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.3 | $3.0M | 91k | 33.19 | |
| Aclx Us Common Stock (ACLX) | 1.3 | $2.9M | 44k | 65.60 | |
| Soleno Therapeutics (SLNO) | 1.2 | $2.7M | 37k | 71.45 | |
| Nams Uq Equity Ordinary Shares (NAMS) | 1.0 | $2.2M | 108k | 20.47 | |
| Vrna Us Sponsored Ads (VRNA) | 1.0 | $2.2M | 35k | 63.49 | |
| Irhythm Technologies (IRTC) | 0.9 | $2.2M | 21k | 104.68 | |
| Summit Therapeutics (SMMT) | 0.9 | $2.0M | 105k | 19.29 | |
| Revolution Medicines (RVMD) | 0.9 | $1.9M | 55k | 35.36 | |
| Bicara Therapeutics (BCAX) | 0.7 | $1.6M | 120k | 13.03 | |
| Merus N V (MRUS) | 0.7 | $1.5M | 35k | 42.09 | |
| Janux Therapeutics (JANX) | 0.6 | $1.3M | 47k | 27.00 | |
| Mreo Us Equity Spon Ads (MREO) | 0.4 | $878k | 390k | 2.25 | |
| Autl Us Spon Ads (AUTL) | 0.3 | $743k | 480k | 1.55 | |
| Crbp Us Com New (CRBP) | 0.2 | $522k | 98k | 5.31 | |
| Cabaletta Bio (CABA) | 0.1 | $253k | 182k | 1.39 |
